Green cross

South Korean biotech firm Green Cross has laid a solid foundation for mid-to-long-term expansion in the U.S. market through its intravenous immunoglobulin product Alyglo. Analysts at Heungkuk

In a brazen early-morning assault on a new north Houston business, thieves used a U-Haul truck to smash through the front wall of the Green Cross smoke shop near the North Freeway and Gulf Bank